⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for precision oncology

Every month we try and update this database with for precision oncology cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNCT03452774
Cancer, Metasta...
Cancer
Cancer of Pancr...
Cancer of Liver
Cancer of Stoma...
Cancer Liver
Cancer of Rectu...
Cancer of Kidne...
Cancer of Esoph...
Cancer of Cervi...
Cancer of Colon
Cancer of Laryn...
Cancer, Lung
Cancer, Breast
Cancer, Advance...
Cancer Prostate
Cancer of Neck
Cancer of Skin
Neuroendocrine ...
Carcinoma
Mismatch Repair...
BRCA Gene Rearr...
Non Hodgkin Lym...
Leukemia
Non Small Cell ...
Cholangiocarcin...
Glioblastoma
Central Nervous...
Melanoma
Urothelial Carc...
Bladder Cancer
Ovarian Cancer
Endometrial Can...
Testicular Canc...
Breast Cancer
COVID
Myelofibrosis
Myeloproliferat...
Myeloproliferat...
Follicular Lymp...
Mantle Cell Lym...
Marginal Zone L...
Myelodysplastic...
Clinical Trial ...
- Massive Bio, Inc.
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesNCT04541108
Solid Tumor
Rilvegostomig
Volrustomig
Sabestomig
Pembrolizumab
18 Years - Presage Biosciences
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid TumorsNCT04106492
Cancer
SQ3370
18 Years - Shasqi, Inc.
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, and Sabestomig in HNSCCNCT06366451
Head and Neck S...
Rilvegostomig
Volrustomig
Sabestomig
Pembrolizumab
18 Years - Presage Biosciences
A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 TrialNCT04786600
Metastatic Colo...
Signatera ctDNA...
pre-specified s...
18 Years - 99 YearsUniversity of Florida
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract TumorsNCT04683939
Solid Tumor
Gastric Cancer
Gastroesophagea...
Esophageal Aden...
Pancreatic Canc...
Biliary Tract C...
Cholangiocarcin...
Metastatic Canc...
BNT141
Nab-paclitaxel
Gemcitabine
18 Years - BioNTech SE
Intratumoral Microdosing of TAK-981 in Head and Neck CancerNCT04065555
Head and Neck C...
TAK-981
Cetuximab
Avelumab
TAK-981 + Cetux...
TAK-981 + Avelu...
18 Years - Presage Biosciences
Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast CancerNCT02008994
Metastatic Brea...
Genomic and Pro...
18 Years - Sanford Health
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesNCT04541108
Solid Tumor
Rilvegostomig
Volrustomig
Sabestomig
Pembrolizumab
18 Years - Presage Biosciences
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid TumorsNCT04106492
Cancer
SQ3370
18 Years - Shasqi, Inc.
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesNCT04541108
Solid Tumor
Rilvegostomig
Volrustomig
Sabestomig
Pembrolizumab
18 Years - Presage Biosciences
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsNCT05199584
Solid Tumors Wi...
ENV-101 (talade...
18 Years - Endeavor Biomedicines, Inc.
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in AustraliaNCT04891718
Solid Tumour
MVC-101
Nivolumab
MVC-101 + Nivol...
18 Years - Presage Biosciences
PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCCNCT06062602
Head and Neck S...
TAK-676
Carboplatin
5-FU
Paclitaxel
TAK-676 + Carbo...
Carboplatin + P...
Carboplatin + 5...
TAK-676 + Carbo...
TAK-676 + Carbo...
18 Years - Presage Biosciences
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue SarcomaNCT03056599
Soft Tissue Sar...
Multiple drug m...
CIVO device
18 Years - Presage Biosciences
Intratumoral Microdosing of TAK-981 in Head and Neck CancerNCT04065555
Head and Neck C...
TAK-981
Cetuximab
Avelumab
TAK-981 + Cetux...
TAK-981 + Avelu...
18 Years - Presage Biosciences
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: